Melatonin and Osteogenic Loading on Osteopenia
Running, not enrolling · Early Phase 1 · Has a placebo group
Conditions studied: Osteopenia
In brief
This study will be assessing the efficacy of melatonin and/or osteogenic loading on modulating bone health in an osteopenic population.
Key facts
- Study ID
- NCT04233112
- Run by
- Duquesne University
- People needed
- 40
- Starts
- 2020-05-26
- Expected to finish
- 2025-09-01
- Last updated by the study team
- 2025-08-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- OsteoStrong® in Scott Towne Center — Pittsburgh, Pennsylvania, United States
- Duquesne University — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.